1.84
price down icon9.36%   -0.19
 
loading

NanoViricides Inc Aktie (NNVC) Neueste Nachrichten

pulisher
05:34 AM

How to build a dashboard for NanoViricides Inc. stockEarnings Performance Report & Risk Controlled Swing Alerts - newser.com

05:34 AM
pulisher
04:35 AM

How NanoViricides Inc. stock trades after earningsDollar Strength & Low Risk Investment Opportunities - newser.com

04:35 AM
pulisher
03:17 AM

Is NanoViricides Inc. stock undervalued vs historical averagesPortfolio Return Report & Verified High Yield Trade Plans - newser.com

03:17 AM
pulisher
03:06 AM

Is NanoViricides Inc. stock a defensive play amid uncertainty2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com

03:06 AM
pulisher
02:57 AM

How to use Fibonacci retracement on NanoViricides Inc.2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com

02:57 AM
pulisher
Nov 03, 2025

Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - Norwich Bulletin

Nov 03, 2025
pulisher
Nov 03, 2025

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides - Waynesboro Record Herald

Nov 03, 2025
pulisher
Nov 03, 2025

NanoViricides to Present Antiviral Drug Pipeline at Spartan Capital Investor Conference - citybuzz -

Nov 03, 2025
pulisher
Nov 03, 2025

Why NanoViricides Inc. stock appeals to dividend seekersJobs Report & High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why NanoViricides Inc. stock is upgraded to buy2025 Trade Ideas & Smart Swing Trading Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - ACCESS Newswire

Nov 03, 2025
pulisher
Nov 03, 2025

Can NanoViricides Inc. (NV3P) stock ride next bull market cycleMarket Risk Report & Consistent Income Trade Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can NanoViricides Inc. stock hit consensus price targetsMarket Movement Recap & Consistent Profit Trading Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

NanoViricides to present at Spartan Capital Investor Conference 2025 in New York - Proactive financial news

Nov 03, 2025
pulisher
Nov 03, 2025

How NanoViricides Inc. (NV3P) stock trades after rate cutsJuly 2025 PreEarnings & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Combining machine learning predictions for NanoViricides Inc.Trade Volume Summary & AI Powered Buy and Sell Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will NanoViricides Inc. stock split attract more investorsIPO Watch & Accurate Technical Buy Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What MACD trends signal for NanoViricides Inc. stock2025 Top Gainers & Fast Gain Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Has NanoViricides Inc. found a price floorTrade Performance Summary & Detailed Earnings Play Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using portfolio simulators with NanoViricides Inc. includedInflation Watch & Technical Pattern Alert System - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

NanoViricides, Inc. Has Filed its Annual Report - The Marion Star

Nov 02, 2025
pulisher
Nov 02, 2025

NanoViricides Dual Track Clinical Strategy Explained by a Research ReportBroad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses - The Holland Sentinel

Nov 02, 2025
pulisher
Oct 31, 2025

NanoViricides targets broad-spectrum virus threats – ICYMI - Proactive financial news

Oct 31, 2025
pulisher
Oct 31, 2025

Identifying reversal signals in NanoViricides Inc.2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Detecting support and resistance levels for NanoViricides Inc.Weekly Trade Report & Community Verified Trade Alerts - newser.com

Oct 31, 2025
$37.78
price up icon 1.31%
$28.97
price up icon 0.85%
$102.19
price up icon 0.70%
$104.11
price up icon 0.15%
biotechnology ONC
$312.11
price up icon 0.22%
$185.53
price down icon 0.61%
Kapitalisierung:     |  Volumen (24h):